Alembic Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for prazosin hydrochloride capsules USP in 1 mg, 2 mg, and 5 mg strengths, the company said in an exchange filing.
The drug is a generic version of Pfizer Inc's Minipress capsules.
It is indicated for the treatment of hypertension to lower blood pressure.
According to data by IQVIA, the drug had sales of approximately $50 mln for the 12-month period ended December.
Mumbai News: RPF Andheri Returns Lost Bag With Valuables Worth ₹2 Lakh To Woman Passenger On Local Train
Maharashtra Assembly: 'Mumbai Suburban Train Deaths Hit 7,565 In Past 3 Years,' Says Transport Minister Pratap Sarnaik; VIDEO
Mumbai News: 54-Year-Old Businessman Files FIR Against Bengaluru-Based Art Dealer For Selling Forged Paintings Worth ₹45 Lakh
Maharashtra Assembly: 'Pune And Bhiwandi Identified As Counterfeit Currency Hubs,' Says CM Devendra Fadnavis
Shares of the company traded 0.8% lower at ₹521.05 on the NSE, at 09:15 IST.
